All Phenotypes E2f1<tm1Njd> MGI Mouse

Phenotypes associated with this allele

Jump to	Allelic Composition	Genetic Background	Genotype ID
hm1	E2f1^tm1Njd/E2f1^tm1Njd	involves: 129S2/SvPas * C57BL/6	MGI:3840273
hm2	E2f1^tm1Njd/E2f1^tm1Njd	involves: 129S2/SvPas * SKH1	MGI:3840838
cx3	E2f1^tm1Njd/E2f1⁺ Rb1^tm1Tyj/Rb1⁺	either: 129S2/SvPas or (involves: 129S2/SvPas * C57BL/6)	MGI:3840352
cx4	E2f1^tm1Njd/E2f1^tm1Njd Rb1^tm1Tyj/Rb1^tm1Tyj	either: 129S2/SvPas or (involves: 129S2/SvPas * C57BL/6)	MGI:3840350
cx5	E2f1^tm1Njd/E2f1⁺ Rb1^tm1Tyj/Rb1^tm1Tyj	either: 129S2/SvPas or (involves: 129S2/SvPas * C57BL/6)	MGI:3840351
cx6	E2f1^tm1Njd/E2f1^tm1Njd Rb1^tm1Tyj/Rb1⁺	either: 129S2/SvPas or (involves: 129S2/SvPas * C57BL/6)	MGI:3840353
cx7	E2f1^tm1Njd/E2f1^tm1Njd E2f3^tm1Lees/E2f3^tm1Lees	involves: 129S2/SvPas	MGI:3840609
cx8	E2f1^tm1Njd/E2f1⁺ E2f3^tm1Lees/E2f3^tm1Lees	involves: 129S2/SvPas	MGI:3840607
cx9	E2f1^tm1Njd/E2f1^tm1Njd E2f3^tm1Lees/E2f3⁺	involves: 129S2/SvPas	MGI:3840610
cx10	E2f1^tm1Njd/E2f1^tm1Njd E2f3^tm2Lees/E2f3^tm2Lees	involves: 129S2/SvPas * 129S4/SvJae * C57BL/6	MGI:3840227
cx11	E2f1^tm1Njd/E2f1^tm1Njd E2f3^tm3Lees/E2f3^tm3Lees	involves: 129S2/SvPas * 129S4/SvJae * C57BL/6	MGI:3840229
cx12	E2f1^tm1Njd/E2f1^tm1Njd Klhl40^tm1.1Itl/Klhl40^tm1.1Itl	involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6N	MGI:5770003
cx13	E2f1^tm1Njd/E2f1^tm1Njd Trp53^tm1Brd/Trp53^tm1Brd	involves: 129S2/SvPas * 129S7/SvEvBrd * SKH1	MGI:3840839

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

respiratory system

increased lung non-small cell carcinoma incidence ( J:33099 )

increased lung adenocarcinoma incidence ( J:33099 )

reproductive system

seminiferous tubule degeneration ( J:33099 )

• empty and degenerating tubules by 9 months becoming more obvious by 12 months

increased Leydig cell number ( J:33099 )

• interstitial cells are more numerous than normal at 2.5 months

• cell numbers remain stable or increase somewhat with age

decreased testis weight ( J:33099 )

• testis weights average 44% of controls and only 10% in most extreme instances

testicular atrophy ( J:33099 )

• seen between 9 and 15 months

increased reproductive system tumor incidence ( J:33099 )

• about 1/3 of tumors are found in the reproductive tract

• epididymal tumors between the ducts in space normally occupied by smooth muscle or connective tissue

• endometrial stroma sarcomas

endocrine/exocrine glands

abnormal gland morphology ( J:89720 )

abnormal salivary gland morphology ( J:33099 )

• histology deteriorates with age

• decrease in overall size of the salivary gland complex with age

• notably, mucous cells of the sublingual gland appear normal

abnormal parotid gland morphology ( J:33099 )

• abnormally large and swollen cell nuclei and many binucleate cells

• cells producing amylase are abnormal

abnormal submandibular gland morphology ( J:33099 )

• abnormally large and swollen cell nuclei and many binucleate cells

• abnormalities restricted to mucous cells

• serous cells are normal

• fewer mucous acini compared to serous acini despite an increase in the size of individual mucous cells

abnormal exorbital lacrimal gland morphology ( J:33099 )

• cells with enlarged nuclei

abnormal pancreas morphology ( J:89720 )

abnormal exocrine pancreas morphology ( J:33099 )

• similar abnormalities to salivary glands

• cells with enlarged or doubled nuclei

• histology deteriorates with age

• decrease in size with age

abnormal pancreatic islet morphology ( J:89720 )

• ratio of glucagon secreting to insulin secreting cells elevated at 16 weeks

• ratio of alpha to beta cells is increased

• ratio of glucagon secreting to insulin secreting cells normal at 4 weeks of age

abnormal pancreatic beta cell morphology ( J:89720 )

• total beta cell area is reduced

decreased pancreatic islet number ( J:89720 )

• relative to body weight

small pancreatic islets ( J:89720 )

• reduced cross-sectional area relative to body weight

decreased pancreas weight ( J:89720 )

• disproportionately greater reduction than body weight

seminiferous tubule degeneration ( J:33099 )

• empty and degenerating tubules by 9 months becoming more obvious by 12 months

increased Leydig cell number ( J:33099 )

• interstitial cells are more numerous than normal at 2.5 months

• cell numbers remain stable or increase somewhat with age

decreased testis weight ( J:33099 )

• testis weights average 44% of controls and only 10% in most extreme instances

testicular atrophy ( J:33099 )

• seen between 9 and 15 months

decreased insulin secretion ( J:89720 )

• isolated islets release significantly reduced but nevertheless robust levels of insulin

growth/size/body

decreased body weight ( J:33099 , J:89720 )

• body weight more or less normal up to 8.7 months (J:33099)

• considerable weight loss in 12-15 month old animals (J:33099)

neoplasm

increased metastatic potential ( J:33099 )

• sarcomas are very metastatic

increased tumor incidence ( J:33099 )

• up to 34% of homozygotes have tumors by 15 months of age

increased lymphoma incidence ( J:33099 )

• develop between 12.5 and 16.5 months of age

• lymphoproliferative syndrome develops in a small number of females between 8 and 15 months

• often leads to death

• involves enlarged lymph nodes, splenomegaly, glomerulonephritis, anemia (hematocrits of 8-15%)

increased histiocytic sarcoma incidence ( J:33099 )

increased lung non-small cell carcinoma incidence ( J:33099 )

increased lung adenocarcinoma incidence ( J:33099 )

increased reproductive system tumor incidence ( J:33099 )

• about 1/3 of tumors are found in the reproductive tract

• epididymal tumors between the ducts in space normally occupied by smooth muscle or connective tissue

• endometrial stroma sarcomas

digestive/alimentary system

abnormal exocrine pancreas morphology ( J:33099 )

• similar abnormalities to salivary glands

• cells with enlarged or doubled nuclei

• histology deteriorates with age

• decrease in size with age

abnormal salivary gland morphology ( J:33099 )

• histology deteriorates with age

• decrease in overall size of the salivary gland complex with age

• notably, mucous cells of the sublingual gland appear normal

abnormal parotid gland morphology ( J:33099 )

• abnormally large and swollen cell nuclei and many binucleate cells

• cells producing amylase are abnormal

abnormal submandibular gland morphology ( J:33099 )

• abnormally large and swollen cell nuclei and many binucleate cells

• abnormalities restricted to mucous cells

• serous cells are normal

• fewer mucous acini compared to serous acini despite an increase in the size of individual mucous cells

vision/eye

abnormal exorbital lacrimal gland morphology ( J:33099 )

• cells with enlarged nuclei

adipose tissue

decreased total body fat amount ( J:89720 )

• reduced total body fat mass

abnormal fat cell differentiation ( J:89720 )

• impaired adipocyte differentiation

increased adipocyte glucose uptake ( J:89720 )

• more efficient

homeostasis/metabolism

decreased insulin secretion ( J:89720 )

• isolated islets release significantly reduced but nevertheless robust levels of insulin

decreased circulating glucose level ( J:89720 )

• fasting glucose levels lower than in controls

abnormal circulating insulin level ( J:89720 )

• insulin levels do not increase in a glucose tolerance test

decreased circulating insulin level ( J:89720 )

• fasting insulin levels lower than controls

impaired glucose tolerance ( J:89720 )

• reduced glucose clearance in a glucose tolerance test

increased insulin sensitivity ( J:89720 )

cellular

abnormal fat cell differentiation ( J:89720 )

• impaired adipocyte differentiation

increased adipocyte glucose uptake ( J:89720 )

• more efficient

Allelic Composition	E2f1^tm1Njd/E2f1^tm1Njd
Genetic Background	involves: 129S2/SvPas * SKH1

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
E2f1^tm1Njd mutation (1 available); any E2f1 mutation (25 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

integument

increased sensitivity to skin irradiation ( J:97525 )

• increased sensitivity to UVB than controls at lower doses

• increased apoptotic response

Allelic Composition	E2f1^tm1Njd/E2f1⁺ Rb1^tm1Tyj/Rb1⁺
Genetic Background	either: 129S2/SvPas or (involves: 129S2/SvPas * C57BL/6)

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
E2f1^tm1Njd mutation (1 available); any E2f1 mutation (25 available)
Rb1^tm1Tyj mutation (5 available); any Rb1 mutation (106 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

premature death ( J:47108 )

• increased survival relative to Rb1^tm1Tyj heterozygotes, 11.6 months on a 129 background and up to 12.6 months on a mixed background

neoplasm

increased tumor incidence ( J:47108 )

• develop grossly detectable pituitary tumors

increased thyroid adenoma incidence ( J:47108 )

• fewer thyroid C-cell adenomas than in Rb1^tm1Tyj heterozygotes

endocrine/exocrine glands

increased thyroid adenoma incidence ( J:47108 )

• fewer thyroid C-cell adenomas than in Rb1^tm1Tyj heterozygotes

Allelic Composition	E2f1^tm1Njd/E2f1^tm1Njd Rb1^tm1Tyj/Rb1^tm1Tyj
Genetic Background	either: 129S2/SvPas or (involves: 129S2/SvPas * C57BL/6)

Find Mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

prenatal lethality, complete penetrance ( J:47108 )

• no double homozygotes recovered after birth

Allelic Composition	E2f1^tm1Njd/E2f1⁺ Rb1^tm1Tyj/Rb1^tm1Tyj
Genetic Background	either: 129S2/SvPas or (involves: 129S2/SvPas * C57BL/6)

Find Mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

prenatal lethality, complete penetrance ( J:47108 )

• no mice of this genotype recovered after birth

Allelic Composition	E2f1^tm1Njd/E2f1^tm1Njd Rb1^tm1Tyj/Rb1⁺
Genetic Background	either: 129S2/SvPas or (involves: 129S2/SvPas * C57BL/6)

Find Mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

premature death ( J:47108 )

• increased survival relative to Rb1^tm1Tyj heterozygotes, 15.2 months on a 129 background and up to 17 months on a mixed background

neoplasm

increased pituitary gland tumor incidence ( J:47108 )

• only about 62% develop pituitary tumors

• pituitary tumors are smaller than Rb1^tm1Tyj heterozygotes but histologically indistinguishable

increased thyroid adenoma incidence ( J:47108 )

• fewer thyroid C-cell adenomas than in Rb1^tm1Tyj heterozygotes

increased hemangioma incidence ( J:47108 )

endocrine/exocrine glands

adrenal medulla hyperplasia ( J:47108 )

abnormal thyroid gland morphology ( J:47108 )

• thyroid gland degeneration after 14 months of age

increased pituitary gland tumor incidence ( J:47108 )

• only about 62% develop pituitary tumors

• pituitary tumors are smaller than Rb1^tm1Tyj heterozygotes but histologically indistinguishable

increased thyroid adenoma incidence ( J:47108 )

• fewer thyroid C-cell adenomas than in Rb1^tm1Tyj heterozygotes

reproductive system

uterine hemorrhage ( J:47108 )

cardiovascular system

uterine hemorrhage ( J:47108 )

nervous system

increased pituitary gland tumor incidence ( J:47108 )

• only about 62% develop pituitary tumors

• pituitary tumors are smaller than Rb1^tm1Tyj heterozygotes but histologically indistinguishable

Allelic Composition	E2f1^tm1Njd/E2f1^tm1Njd E2f3^tm1Lees/E2f3^tm1Lees
Genetic Background	involves: 129S2/SvPas

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
E2f1^tm1Njd mutation (1 available); any E2f1 mutation (25 available)
E2f3^tm1Lees mutation (1 available); any E2f3 mutation (32 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

embryonic lethality during organogenesis, complete penetrance ( J:75765 )

• die between E9.5 and E10.5

• embryos normal at E9.5

• much smaller than littermates at E10.5

Allelic Composition	E2f1^tm1Njd/E2f1⁺ E2f3^tm1Lees/E2f3^tm1Lees
Genetic Background	involves: 129S2/SvPas

Find Mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

lethality throughout fetal growth and development, complete penetrance ( J:75765 )

• mice do not survive to E18.5 but are present at E13.5

Allelic Composition	E2f1^tm1Njd/E2f1^tm1Njd E2f3^tm1Lees/E2f3⁺
Genetic Background	involves: 129S2/SvPas

Find Mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

growth/size/body

slow postnatal weight gain ( J:75765 )

• surviving mice fail to gain weight at the same rate as littermates

reproductive system

testicular atrophy ( J:75765 )

• exacerbated

• no loss of leydig cells

endocrine/exocrine glands

testicular atrophy ( J:75765 )

• exacerbated

• no loss of leydig cells

Allelic Composition	E2f1^tm1Njd/E2f1^tm1Njd E2f3^tm2Lees/E2f3^tm2Lees
Genetic Background	involves: 129S2/SvPas * 129S4/SvJae * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
E2f1^tm1Njd mutation (1 available); any E2f1 mutation (25 available)
E2f3^tm2Lees mutation (0 available); any E2f3 mutation (32 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

neonatal lethality, incomplete penetrance ( J:147270 )

• significantly reduced survival to weaning

• normal numbers at birth

• most mortality is in the neonatal period

growth/size/body

decreased body weight ( J:147270 )

• double homozygotes weight about 1/3 of controls

skeleton

abnormal cartilage morphology ( J:147270 )

• mature cartilage present

abnormal long bone epiphyseal plate morphology ( J:147270 )

• chondrocytes disorganized

• stacked structures are not seen in femurs

abnormal chondrocyte morphology ( J:147270 )

• abnormal morphology

• 1.5-2 fold larger than normal in resting, columnar, and hypertrophic zones

• increased variability in size

cellular

abnormal cell cycle ( J:147270 )

• MEFs in culture sometimes display impaired re-entry into the cell cycle

decreased cell proliferation ( J:147270 )

• impaired asynchronous proliferation of MEFs in culture

Allelic Composition	E2f1^tm1Njd/E2f1^tm1Njd E2f3^tm3Lees/E2f3^tm3Lees
Genetic Background	involves: 129S2/SvPas * 129S4/SvJae * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
E2f1^tm1Njd mutation (1 available); any E2f1 mutation (25 available)
E2f3^tm3Lees mutation (0 available); any E2f3 mutation (32 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

normal phenotype

no abnormal phenotype detected ( J:147270 )

• no affect on viability to weaning

• fertility is normal

Allelic Composition	E2f1^tm1Njd/E2f1^tm1Njd Klhl40^tm1.1Itl/Klhl40^tm1.1Itl
Genetic Background	involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6N

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
E2f1^tm1Njd mutation (1 available); any E2f1 mutation (25 available)
Klhl40^tm1.1Itl mutation (0 available); any Klhl40 mutation (26 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

mortality/aging ( J:227534 )

N	• mice are born viable and survive weaning

growth/size/body

decreased body size ( J:227534 )

Allelic Composition	E2f1^tm1Njd/E2f1^tm1Njd Trp53^tm1Brd/Trp53^tm1Brd
Genetic Background	involves: 129S2/SvPas * 129S7/SvEvBrd * SKH1

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
E2f1^tm1Njd mutation (1 available); any E2f1 mutation (25 available)
Trp53^tm1Brd mutation (5 available); any Trp53 mutation (232 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

integument

increased sensitivity to skin irradiation ( J:97525 )

• increased apoptosis response to UVB

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 04/23/2024 MGI 6.23